Adam Temple (Courtesy photo)

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)

Ask anyone who has moved from one legal state to another, and they’ll tell you the same story: A cannabis brand they loved in California was unrecognizable in Maryland. Same logo, same packaging, completely different product.

Cannabis consumers notice this — constantly. They know inconsistency has become one of the industry’s most persistent complaints, showing up across every category: flower, vapes, edibles, concentrates.

It is the clearest evidence that cannabis still hasn’t learned to manufacture like a real sector.

The basic reason is structural. Because product can’t legally cross state lines, every state market is its own island. An operator in seven states runs seven separate supply chains, sourcing seven batches of biomass, handing them to seven teams, and hoping the output lands in the same place.

In this way, “the same brand” is often seven different products wearing one label.

When is cannabis interstate commerce happening?

But there’s a real reason to think those walls preventing interstate commerce will come down.

In April, the Department of Justice moved state-licensed medical cannabis to Schedule 3. In June, the U.S. Drug Enforcement Administration opened a hearing on broader rescheduling. California, Oregon, and Washington already have interstate commerce statutes on the books, waiting for the federal green light.

Recently, Glass House Brands, one of the country’s largest cultivators, told MJBizDaily the age of legitimate interstate commerce is at hand, citing its new DEA export registration and a first shipment of flower to Europe.

Cannabis will almost certainly be federally regulated within a decade. The harder question is when. A final rule could come this year, or litigation could stretch it out for years. Any national strategy that depends on knowing that date is really just a hope.

Glass House’s confidence rests on the supply side, on moving flower across borders. Making a branded product that performs the same in every state is the next challenge, and the operators pulling ahead are solving it. They treat interstate commerce as a manufacturing capability: the ability to make the identical product in every state they operate in.

That capability takes years to build and does not appear the moment the law changes. So they are building it now, inside the current patchwork, while everyone else waits for permission.

How can a cannabis operator prepare for interstate commerce?

None of this requires reinventing the wheel. Other industries solved this exact problem generations ago.

Consider a bakery. A regional chain runs 20 locations across five states and hands you the same loaf at every one. That consistency comes from its ingredients. Flour and sugar arrive refined to a known specification, so the recipe produces the same result in every kitchen. Repeatable inputs make repeatable outputs.

The wine industry goes further. Some of the best-selling wines in the country are blends, engineered to taste the same year after year even though the grapes and the weather change with every harvest. Blending delivers a consistent experience on top of an inconsistent raw material, which is exactly cannabis’s problem with biomass. In both industries, consistency is engineered into the inputs long before the finished product.

What’s the secret to cannabis consistency?

In cannabis, the shift is to treat extraction as the step that produces standardized ingredients, which formulation then turns into finished products.

The old model asks four independent variables to line up by chance: the biomass on the market, the process run on it, the product that results, and whether consumers still want that product when it reaches the shelf. For years, operators managed that gamble with an “extract artist,” a talented specialist who kept the whole process in his head and produced great material by feel.

You cannot clone that specialist across seven states, and a process living in one person’s intuition will never be repeatable.

The better model splits manufacturing into two disciplines. Extraction purifies biomass into two standardized ingredients, a high-purity THC isolate and a high-terpene extract, each made to a testable specification. Formulation recombines them just in time, following a documented recipe with defined targets for potency, viscosity, color, and terpene profile. Every batch is produced to a spec you can measure.

This unlocks a national brand under current law. You source biomass separately in each state, as the rules require, and still land on the same finished product, as long as you purify that local biomass into ingredients that hit the same spec. Consistency no longer depends on where the plant grew or who ran the lab that day. That is your own version of interstate commerce, and it is legal today.

When should cannabis operators prepare for interstate commerce?

The payoff arrives well before any border opens. Just-in-time formulation ends the guessing game of betting on next quarter’s hot flavor, producing it in bulk, then watching the trend move and leave you with dead inventory that ties up cash. Two standardized, shelf-stable ingredients let you formulate to what the market wants, when it wants it.

This is a rare bet with no real downside. The work that positions you to scale nationally the day the borders open is the same work that lowers inventory risk, frees cash, and makes your brand more consistent right now.

Whenever interstate commerce arrives, in 18 months or in five years, there will be two kinds of operators. One will start building national consistency from zero, under deadline, while competitors move. The other will already have it and will simply flip a switch. The date is out of your hands. Readiness is the one part you can build today.

Adam Temple is the founder of Evolved Extraction Solutions and one of the cannabis industry’s most forward-leaning minds in extraction science and production strategy.